CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-15 | Polymeropoulos Mihael Hristos President and CEO | Sale | −39,150 | $13.00 | $509K | 1,303,747 |
| 2020-12-15 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −46,663 | 0 | ||
| 2020-12-14 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +61,520 | $8.75 | $538K | 1,347,283 |
| 2020-12-14 | Polymeropoulos Mihael Hristos President and CEO | Sale | −51,049 | $13.19 | $673K | 1,296,234 |
| 2020-12-14 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −61,520 | 46,663 | ||
| 2020-12-11 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +41,817 | $8.75 | $366K | 1,320,816 |
| 2020-12-11 | Polymeropoulos Mihael Hristos President and CEO | Sale | −35,053 | $12.88 | $451K | 1,285,763 |
| 2020-12-11 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −41,817 | 108,183 | ||
| 2020-08-20 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −3,710 | $11.08 | $41K | 56,290 |
| 2020-08-14 | Williams Timothy SVP & General Counsel | Sale | −3,684 | $11.81 | $44K | 79,356 |
| 2020-08-12 | Jones Aranthan II Chief Corp. Affairs Officer | Sale | −7,200 | $11.81 | $85K | 75,487 |
| 2020-07-27 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award | +17,344 | 78,097 | ||
| 2020-07-27 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2020-07-27 | Jones Aranthan II Chief Corp. Affairs Officer | Sale | −7,313 | $10.62 | $78K | 82,687 |
| 2020-06-11 | Watkins Thomas Director | Grant or award | +5,000 | 40,323 | ||
| 2020-06-11 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-11 | Ward Anne Sempowski Director | Grant or award | +5,000 | 5,000 | ||
| 2020-06-11 | Ward Anne Sempowski Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-11 | Mitchell Stephen Ray Director | Grant or award | +5,000 | 5,200 | ||
| 2020-06-11 | Mitchell Stephen Ray Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 13 of 20 · 387 trades